(Q53364934)

13 May 2018

meta-analysis

0 references

title

TREM2 variants and risk of Alzheimer's disease: a meta-analysis. (English)

1 reference

13 May 2018

0 references

0 references

Yanjun Lu

1

1 reference

13 May 2018

Wei Liu

series ordinal

2

1 reference

13 May 2018

Xiong Wang

series ordinal

3

1 reference

13 May 2018

publication date

3 June 2015

1 reference

13 May 2018

number of pages

8

1 reference

inferred from page(s)

published in

Neurological Sciences

1 reference

13 May 2018

volume

36

1 reference

13 May 2018

issue

10

1 reference

13 May 2018

page(s)

1881-1888

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1007/s10072-015-2274-2

exact match

0 references

cites work

Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Novel APP K724M mutation causes Chinese early-onset familial Alzheimer's disease and increases amyloid-β42 to amyloid-β40 ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Endogenous expression of FAD-linked PS1 impairs proliferation, neuronal differentiation and survival of adult hippocampal progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

ABCA7 gene and the risk of Alzheimer's disease in Han Chinese in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Genetic variation in PICALM and Alzheimer's disease risk in Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

CR1, ABCA7, and APOE genes affect the features of cognitive impairment in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

CR1 is potentially associated with rate of decline in sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

A novel Alzheimer disease locus located near the gene encoding tau protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

TREM2 Variants in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

TREM2 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

The innate immune system in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Association of two polymorphisms rs2910164 in miRNA-146a and rs3746444 in miRNA-499 with rheumatoid arthritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Reelin gene variants and risk of autism spectrum disorders: an integrated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Genetic associations of CLU rs9331888 polymorphism with Alzheimer's disease: A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

TREM2 is associated with the risk of Alzheimer's disease in Spanish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

TREM2 analysis and increased risk of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Heterozygous TREM2 mutations in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2274-2

Lack of genetic association between TREM2 and late-onset Alzheimer's disease in a Japanese population.

21 January 2018

1 reference

12 December 2020

Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer's disease

1 reference

12 December 2020

A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy

1 reference

12 December 2020

Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients.

1 reference

12 December 2020

The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia

1 reference

12 December 2020

R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia

1 reference

12 December 2020

Coding variants in TREM2 increase risk for Alzheimer's disease

1 reference

12 December 2020

TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.

1 reference

12 December 2020

10.1007/S10072-015-2274-2

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018